BUFOMIX EASYНALER® contains formoterol and budesonide, which are in the form of a dry powder for inhalation in a metered dose inhaler Easyhaler®.
BUDESONID is a glucocorticosteroid that, when inhaled, has a dose-dependent anti-inflammatory effect in the airways, which reduces the symptoms of bronchial asthma.
FORMOTHEROL is a selective adrenostimulant of β2-adrenoceptors, which when inhaled provides rapid and long-term relaxation of bronchial smooth muscle in patients with reversible airway obstruction. The bronchodilator effect is dose-dependent and occurs within 1–3 minutes. The duration of the effect is at least 12 hours after a single dose.
EASYHALER® is a multi-dose dry powder inhaler, an effective and at the same time easy-to-use inhaler for the treatment of chronic diseases of the respiratory system.
A key feature of the Easyhaler® Inhaler is the design of the device, which is designed to be comfortable to use and to meet patient requirements and to provide high clinical efficacy.
The Easyhaler® range is designed with the need for different medicines at different stages of the disease so that patients can be treated with Easyhaler®, a friend’s easy-to-use inhaler.
Bufomix Easyhaler® is indicated for the regular treatment of bronchial asthma in patients who do not achieve adequate control with inhaled corticosteroids and short-acting β2-adrenoceptor agonists, who use “if necessary”, or for patients who have already achieved adequate control in the use of corticosteroids. and long-acting β2-adrenoceptor agonists.
YURIA-PHARM and ORION, within the framework of a strategic partnership, jointly present a product and carry out projects related to the development of treatment of chronic diseases of the respiratory system.
Powder for inhalation, 1 dose contains budesonide 160 mcg and formoterol fumarate dihydrate 4.5 mcg, 120 doses in the inhaler.